MPAM
KERX

Monarch Partners Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Monarch Partners Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-685,700
Closed -$4.87M – 218
2017
Q3 		$4.87M Buy
685,700
+262,540
+62% +$1.86M 0.47% 86
2017
Q2 		$3.06M Buy
+423,160
New +$3.06M 0.3% 109